What 16 Analyst Ratings Have To Say About Boston Scientific
Portfolio Pulse from Benzinga Insights
In the last quarter, Boston Scientific (NYSE:BSX) received 9 bullish, 6 somewhat bullish, and 1 indifferent rating from 16 analysts. The average price target is $58.25, indicating an upside from the current price of $52.555. The average price target has increased by 7.59% over the past month.
July 12, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific received mostly positive ratings from analysts, indicating potential upside.
The majority of the 16 analysts gave Boston Scientific a bullish or somewhat bullish rating, indicating a positive outlook for the stock. The average price target of $58.25 is higher than the current price of $52.555, suggesting potential upside. This could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100